Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

Conditions:   Esophageal Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: Toripalimab;   Drug: Anlotinib hydrochloride;   Drug: Albumin paclitaxel;   Drug: Cisplatin Sponsor:   Nanfang Hospital, Southern Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials